TransCode Therapeutics (RNAZ)
(Delayed Data from NSDQ)
$0.26 USD
+0.01 (2.41%)
Updated Sep 13, 2024 03:59 PM ET
After-Market: $0.26 0.00 (0.35%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for TransCode Therapeutics Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -18.55 | -17.56 | -6.84 | -2.34 | NA |
Depreciation/Amortization & Depletion | 0.52 | 0.10 | 0.04 | 0.00 | NA |
Net Change from Assets/Liabilities | -1.08 | 1.31 | 0.47 | 0.31 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 1.04 | 0.40 | 1.07 | 1.54 | NA |
Net Cash From Operating Activities | -18.07 | -15.76 | -5.27 | -0.49 | NA |
Property & Equipment | -0.04 | -0.10 | -0.25 | 0.00 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | -0.04 | -0.10 | -0.25 | 0.00 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 15.91 | 0.01 | 26.34 | 0.00 | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 1.19 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | 0.00 | -0.82 | -0.07 | NA |
Net Cash from Financing Activities | 15.91 | 0.01 | 25.52 | 1.12 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | -2.20 | -15.86 | 20.00 | 0.62 | NA |
Cash at Beginning of Period | 4.97 | 20.83 | 0.83 | 0.20 | NA |
Cash at End of Period | 2.77 | 4.97 | 20.83 | 0.83 | NA |
Diluted Net EPS | -103.61 | -1,080.00 | -648.00 | NA | NA |
Fiscal Year End for TransCode Therapeutics Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -8.52 | -3.33 | -18.55 | -14.46 | -9.16 |
Depreciation/Amortization & Depletion | 0.28 | 0.14 | 0.52 | 0.38 | 0.24 |
Net Change from Assets/Liabilities | 0.63 | -0.94 | -1.08 | 0.94 | -0.32 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.33 | 0.18 | 1.04 | 0.73 | 0.33 |
Net Cash From Operating Activities | -6.28 | -3.94 | -18.07 | -12.41 | -8.91 |
Property & Equipment | -0.01 | 0.00 | -0.04 | -0.04 | -0.03 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.01 | 0.00 | -0.04 | -0.04 | -0.03 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 6.87 | 6.09 | 15.91 | 14.93 | 7.68 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | -0.14 |
Net Cash from Financing Activities | 6.87 | 6.09 | 15.91 | 14.93 | 7.54 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 0.59 | 2.15 | -2.20 | 2.48 | -1.40 |
Cash at Beginning of Period | 2.77 | 2.77 | 4.97 | 4.97 | 4.97 |
Cash at End of Period | 3.35 | 4.91 | 2.77 | 7.45 | 3.57 |
Diluted Net EPS | -0.74 | -0.65 | 359.19 | -67.20 | -131.60 |